Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease

被引:203
作者
Desreumaux, P
Brandt, E
Gambiez, L
Emilie, D
Geboes, K
Klein, O
Ectors, N
Cortot, A
Capron, M
Colombel, JF
机构
[1] CHU LILLE,HOP HURIEZ,CLIN MALAD APPAREIL DIGEST & NUTR,F-59037 LILLE,FRANCE
[2] INST PASTEUR,CTR IMMUNOL & BIOL PARASITAIRE,INSERM,U167,F-59019 LILLE,FRANCE
[3] CHU LILLE,HOP HURIEZ,SERV CHIRURG ADULTE OUEST,F-59037 LILLE,FRANCE
[4] INST PARIS SUD CYTOKINES,INSERM,U131,CLAMART,FRANCE
[5] UNIV LEUVEN,DEPT PATHOL,LOUVAIN,BELGIUM
关键词
D O I
10.1016/S0016-5085(97)70116-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Chronic intestinal lesions of patients with Crohn's disease (CD) are associated with a T helper (Th) 1-type cytokine profile, including high levels of interleukin 2 (IL-2) and interferon gamma (IFN-gamma). However, the mechanisms involved in the pathogenesis of the early mucosal lesions are poorly known. The aim of this study was to examine the pattern of Th1- and Th2-type (IL-4, IL-5, and IL-13) cytokines in the early ileal lesions occurring in patients with CD 3 months after ileal resection and ileocolonic anastomosis. Cytokines were also examined in the chronic ileal lesions to look for cytokine patterns related to disease progression. Methods: Ileal biopsy specimens were obtained from 17 patients with CD and 11 controls. Mucosal IL-2, IFN-gamma, IL-4, IL-5, and IL-13 messenger RNA (mRNA) was evaluated by competitive reverse-transcription polymerase chain reaction. Results: The early ileal lesions of patients with CD were associated with a significant increase of IL-4 mRNA and a decrease of IFN-gamma mRNA compared with the normal mucosa of patients with CD or controls. A Th1-type pattern was observed in the chronic ileal lesions, Conclusions: Divergent cytokine patterns are observed during different clinical stages of CD. These observations need to be considered in the development of newer specific therapeutic agents to prevent CD recurrences.
引用
收藏
页码:118 / 126
页数:9
相关论文
共 57 条
  • [1] BOBER LA, 1995, CLIN EXP IMMUNOL, V99, P129
  • [2] BOCHNER BS, 1995, J IMMUNOL, V154, P799
  • [3] CASINIRAGGI V, 1995, J IMMUNOL, V154, P2434
  • [4] THE TH1-TH2 HYPOTHESIS OF HIV-INFECTION - NEW INSIGHTS
    CLERICI, M
    SHEARER, GM
    [J]. IMMUNOLOGY TODAY, 1994, 15 (12): : 575 - 581
  • [5] COLGAN SP, 1994, J IMMUNOL, V153, P2122
  • [6] MATHEMATICAL CONSIDERATIONS OF COMPETITIVE POLYMERASE CHAIN-REACTION
    CONNOLLY, AR
    CLELAND, LG
    KIRKHAM, BW
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 187 (02) : 201 - 211
  • [7] SALICYLATES USED IN INFLAMMATORY BOWEL-DISEASE AND COLCHICINE IMPAIR INTERFERON-GAMMA INDUCED HLA-DR EXPRESSION
    CROTTY, B
    HOANG, P
    DALTON, HR
    JEWELL, DP
    [J]. GUT, 1992, 33 (01) : 59 - 64
  • [8] STIMULATORY AND INHIBITORY EFFECTS OF INTERLEUKIN (IL)-4 AND IL-13 ON THE PRODUCTION OF CYTOKINES BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS - PRIMING FOR IL-12 AND TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION
    DANDREA, A
    MA, XJ
    ASTEAMEZAGA, M
    PAGANIN, C
    TRINCHIERI, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) : 537 - 546
  • [9] PURIFIED PROTEIN DERIVATIVE OF MYCOBACTERIUM-TUBERCULOSIS AND EXCRETORY-SECRETORY ANTIGEN(S) OF TOXOCARA-CANIS EXPAND INVITRO HUMAN T-CELLS WITH STABLE AND OPPOSITE (TYPE-1 T-HELPER OR TYPE-2 T-HELPER) PROFILE OF CYTOKINE PRODUCTION
    DELPRETE, GF
    DECARLI, M
    MASTROMAURO, C
    BIAGIOTTI, R
    MACCHIA, D
    FALAGIANI, P
    RICCI, M
    ROMAGNANI, S
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (01) : 346 - 350
  • [10] Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis
    Desreumaux, P
    Bloget, F
    Seguy, D
    Capron, M
    Cortot, A
    Colombel, JF
    Janin, A
    [J]. GASTROENTEROLOGY, 1996, 110 (03) : 768 - 774